NAD+ precursor that David Sinclair put on the map. Supports cellular energy metabolism, DNA repair pathways, and healthy aging. The supplement longevity enthusiasts take daily.
NMN is a NAD+ precursor that replenishes cellular energy and longevity pathways declining with age. Dosing ranges from 250–1000mg daily; 500mg sublingual taken in AM with resveratrol/quercetin and metformin for synergistic NAD+ amplification. Best taken fasted for absorption optimization.
| Component | Dose | Timing & Monitoring |
|---|---|---|
| NMN (sublingual) | 250–1000 mg | AM, fasted or with fat for absorption; 500mg typical |
| Resveratrol (SIRT1 activator) | 150–500 mg | Co-administered for synergistic NAD+ amplification |
| Quercetin (senolytic) | 250–500 mg | Promotes autophagy and clears senescent cells |
| Optional: Metformin 500mg | 500 mg | AMPK synergy; q6mo LFTs if stacking |
NMN is a direct precursor to NAD+, the critical coenzyme that powers cellular energy metabolism and DNA repair. As NAD+ levels decline 50% by age 60, supplementing with NMN can restore youthful cellular function across multiple pathways.
NMN's bioavailability in humans is ~30% through oral absorption. Once absorbed, it's rapidly converted to NAD+ by salvage pathway enzymes, with NAD+ elevation persisting beyond the ~3 hour half-life of NMN itself. This creates a durable effect on cellular energy metabolism.
| Bioavailability | ~30% (oral) |
| Tmax (time to peak) | 1–2 hours |
| Elimination half-life (NMN) | ~3 hours (but NAD+ elevation persists 24h+) |
| NAD+ elevation duration | 24+ hours (despite short NMN half-life) |
| Protein binding | Low — minimal plasma protein interaction |
| Metabolism | Converted to NAD+ via NMNAT enzymes (salvage pathway). Rate-limiting step is NMNAT activity in target tissues. |
| Active metabolite | NAD+ (main active form), then metabolized by NAD+-consuming enzymes (sirtuins, PARPs, CD38) |
| Excretion | Renal — minimal unchanged NMN in urine. Most converted to NAD+ and downstream metabolites. |
| Food effect | Better absorption on empty stomach or with light meal. High-fat meals may reduce bioavailability slightly. |
NMN dosing ranges widely based on research protocols and biohacking experience. Standard protocols range 250–1000mg daily. Effects on NAD+ are measurable within 2 weeks of consistent use. No cycling required—continuous daily dosing is supported by safety data.
NMN is one of the most-studied NAD+ precursors with human clinical trials demonstrating bioavailability and metabolic effects. Below are key studies supporting its use in healthy aging and metabolism optimization.
NMN's safety profile is excellent, with minimal adverse events in clinical trials up to 1250mg/day. Most side effects are mild, dose-dependent, and resolve with dose reduction or discontinuation.
NMN has minimal known drug interactions as it is not metabolized by major CYP enzymes. However, there are theoretical considerations with NAD+-dependent pathway modulation and other NAD+ precursors.
Start your NMN protocol today. No prescription needed—just quality supplement delivered to your door.